Steven J. Cohen, MD

All articles by Steven J. Cohen, MD

From The Advisory Board

Hot Topics From the 2015 Gastrointestinal Cancers Symposium

Steven J. Cohen, MD

February 3, 2015

Steven J. Cohen, MD, CTA Advisory Board member highlights key science from the 2015 Gastrointestinal Cancer Symposium.

From The Advisory Board

MM-398: A Potential New Option for Metastatic Pancreatic Cancer?

Steven J. Cohen, MD

December 12, 2014

CTA Board Member Steven Cohen, MD, discusses exciting advances regarding treatment options for metastatic pancreatic cancer.

New Gastric Cancer Drug Gets FDA Approval

From The Advisory Board

New Weapon Against Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

Steven J. Cohen, MD

April 24, 2014

FDA approval of ramucirumab offers a new therapy option for patients with gastric cancer, which is notoriously aggressive and difficult disease to treat.

An Exclusive Interview with Steven Cohen, MD

GI Cancers Symposium 2013

ChemotherapyAdvisor.com Editorial Board Recommends High-Impact Abstracts from the 2013 Gastrointestinal Cancers Symposium

Steven J. Cohen, MD

January 23, 2013

Dr. Steven Cohen, MD, of Fox Chase Cancer Center shares his list of recommended abstracts that will be presented at the 2013 Gastrointestinal Cancers Symposium.